Navigation Links
Rochester Medical Reports Fourth Quarter and Year-End Results
Date:11/4/2010

his adjustment reduces net income for amounts received net of taxes paid in connection with one-time settlement of certain litigation.  These amounts were recorded in Other Income in the Statement of Operations for the fiscal year ended September 30, 2009.(2) Amortization of the intangibles acquired in June 2006 asset acquisition from Coloplast AS and Mentor Corporation.  Management believes these assets are appreciating.  This adjustment adds back amortization expense for the three and twelfth months ended September 30, 2010 and 2009 related to certain intangibles. The gross amount of amortization is $163,000 per quarter after taxes of $34,000 for a net amount of $129,000.(3) Compensation expense mandated by ASC 718.  This adjustment adds back the compensation expense recorded for stock options granted to employees and directors that vested during the three and twelve months ended September 30, 2010 and 2009.  The gross amount of compensation expense for the three months ended September 30, 2010 and 2009 is $317,000 and $295,000 net of taxes of $112,000 and $100,000 for net amounts of $205,000 and $195,000 respectively.  The gross amount of compensation expense for the twelve months ended September 30, 2010 and 2009 is $1,481,000 and $1,330,000 net of taxes of $522,000 and $452,000 for net amounts of $959,000 and $878,000 respectively.Condensed Balance Sheets(unaudited)September 30,September 30,20102009AssetsCurrent AssetsCash and equivalents

$
4,545,907$
,365,584Marketable securities

30,967,00729,896,740Accounts receivable

7,858,5406,418,656Inventories

9,240,2919,710,234Prepaid expenses and other assets

846,8991,076,183Deferred income tax

872,8491,153,964Total current assets

54,331,49354,621,361Property and equipment, net

10,017,2399,683,808Deferred income tax

1,175,052768,874Patents, net

229,106224,815Intangible assets, net

5,351,6206,017,944Goodwill4,
'/>"/>

SOURCE Rochester Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
2. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
3. Rochester Medical Announces Fourth Quarter 2009 Earnings Conference Call Thursday, November 5th 2009
4. Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert
5. Rochester Medical Announces First Quarter 2010 Earnings Conference Call Tuesday, January 26, 2010
6. Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
7. AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
8. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... 31, 2015 Noser Health ... to deliver new platform ... citizen-owned health data transaction platform, announced today strategic partnerships ... to engineer and bring to market its global health ... "Our business model is built on trust, ...
(Date:8/28/2015)... 28, 2015  CytomX Therapeutics, Inc., a biopharmaceutical company ... announced the filing of a registration statement on Form ... relating to a proposed initial public offering of its ... and the price range for the offering have not ... stock under the symbol "CTMX" on the NASDAQ Global ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
Breaking Medicine Technology:healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Tobramycin Market, 2015-2019 2
... 16 Metabolic Solutions Development Company (MSDC), www.msdrx.com ... the Study of Diabetes (EASD) annual conference in Stockholm, ... the company,s clinical candidate, MSDC-0160, promotes the proliferation of ... creation of more brown fat.  The research was conducted ...
... LOS ANGELES, Sept. 16 Canon Communications LLC ... United Business Media Limited, a leading global business ... LLC , the management/investment company of Canon Chairman and CEO ... private equity partner.  Apprise and Spectrum acquired Canon in 2005. ...
Cached Medicine Technology:Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes 2Canon Communications to be Sold to United Business Media; Transaction Expands Global Reach of Canon's Advanced Manufacturing and Design Focus 2Canon Communications to be Sold to United Business Media; Transaction Expands Global Reach of Canon's Advanced Manufacturing and Design Focus 3
(Date:8/30/2015)... ... 30, 2015 , ... AvePoint, the established leader ... Silver Sponsor of the Digital Workplace Conference, taking place Sunday, August 30 – ... the event, AvePoint will showcase its file analysis, management, and migration solutions for ...
(Date:8/30/2015)... ... August 30, 2015 , ... Scientists in France say asbestos exposure may put ... cancers. Surviving Mesothelioma has just posted an article on the new research. Click ... the cancer incidence among 2,024 French asbestos plant workers from 1978 to 2009. In ...
(Date:8/30/2015)... ... August 30, 2015 , ... Natural Rest contains a unique ... sleep aids and calming remedies, which help to improve mood disorders and anxiety. Like ... deal of research in the field of regenerative medicine conducted by Dr. Amit Patel ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products ... lead the expansion of global cosmeceutical and skin care brands. Mr. Fernandez ... the last 25 years working in operations, purchasing and management for some of ...
(Date:8/30/2015)... ... August 30, 2015 , ... ... medical devices for the treatment of prostate cancer, has announced the roll-out of ... at the treatment center in Puerto Vallarta, Mexico. , The Sonablate® technology currently ...
Breaking Medicine News(10 mins):Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2
... WASHINGTON, March 23 Four Miami-area residents pleaded guilty ... scheme involving HIV infusion clinics, Acting Assistant Attorney General ... Attorney R. Alexander Acosta of the Southern District of ... Garrido, 69; Gonzalo Nodarse, 38; and Alexis Carrazana, 41; ...
... The Board of Directors of the Radiological Society of ... Watson will become the Society,s executive director on April 1, ... of experience working in key capacities at RSNA and has ... Assistant executive director for finance and administration at RSNA for ...
... for the Cure(R) Advocacy Alliance commended Reps. Debbie Wasserman Schultz ... and Melissa Bean (D-IL) for their efforts to inspire young ... introduction today of the "Breast Cancer E ducation and ... Y oung Act of 2009." The EARLY Act will ...
... Research with canines may one day lead to new therapies ... Joe Bauer got the call on a Friday afternoon. , ... adenocarcinoma, a particularly virulent cancer in dogs, and had been ... owners, from Milford, Mass., were heartbroken and planned to have ...
... A new study published in Epilepsia reveals ... relatively safe and is effective in controlling seizures. The ... positive impact on babies, brain development. , The study ... age across all pediatric neurosurgical centers in Canada between ...
... The US back pain market for drug treatment will ... US Back Pain, a report released today by WWMR, Inc. ... the opioid agonist products that are currently in development. ... anticipated in the clinical community. If pipeline products deliver ...
Cached Medicine News:Health News:Two Doctors and Two Medical Assistants Plead Guilty in $10 Million Medicare Fraud Scheme 2Health News:Two Doctors and Two Medical Assistants Plead Guilty in $10 Million Medicare Fraud Scheme 3Health News:Mark G. Watson Named Executive Director of Radiological Society of North America 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Supports Effort to Encourage Early Breast Health Education 2Health News:Dogs Help in Hunt for New Cancer Drugs 2Health News:Dogs Help in Hunt for New Cancer Drugs 3Health News:Surgery safe for babies and toddlers suffering from seizures 2Health News:US Back Pain Market Approaches $23 Billion in 2018 - Anticipated Long-Acting, Abuse-Resistant Opioids Drive Value 2Health News:US Back Pain Market Approaches $23 Billion in 2018 - Anticipated Long-Acting, Abuse-Resistant Opioids Drive Value 3
... Designed with patient need and ... Orthotic Appliance) family of products effectively ... indications. The Chairback frame attachment provides ... orthosis (LSO) provides superior support for ...
Effectively stabilize and relax your back with the LumboTrain back support....
... to superior immobilization and cervical spine care, one ... already know that the most important function of ... But what you may not know is that ... provides superior immobilization over the leading one-piece rigid ...
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
Medicine Products: